相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Evolution of Pseudomonas aeruginosa Antimicrobial Resistance and Fitness under Low and High Mutation Rates
Gabriel Cabot et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Effect of different renal function on antibacterial effects of piperacillin against Pseudomonas aeruginosa evaluated via the hollow-fibre infection model and mechanism-based modelling
Phillip J. Bergen et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
Cefepime free minimum concentration to minimum inhibitory concentration (fCmin/MIC) ratio predicts clinical failure in patients with Gram-negative bacterial pneumonia
Samuel L. Aitken et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2015)
DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current β-Lactam Antibiotic Doses Sufficient for Critically Ill Patients?
Jason A. Roberts et al.
CLINICAL INFECTIOUS DISEASES (2014)
An international, multicentre survey of -lactam antibiotic therapeutic drug monitoring practice in intensive care units
Gloria Wong et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Genetic Markers of Widespread Extensively Drug-Resistant Pseudomonas aeruginosa High-Risk Clones
Gabriel Cabot et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Overexpression of AmpC and Efflux Pumps in Pseudomonas aeruginosa Isolates from Bloodstream Infections: Prevalence and Impact on Resistance in a Spanish Multicenter Study
Gabriel Cabot et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Optimizing dosage to prevent emergence of resistance - lessons from in vitro models
Renu Singh et al.
CURRENT OPINION IN PHARMACOLOGY (2011)
Treatment and outcomes in carbapenem-resistant Klebsiella pneumoniae bloodstream infections
Elizabeth A. Neuner et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2011)
Wide Dispersion of ST175 Clone despite High Genetic Diversity of Carbapenem-Nonsusceptible Pseudomonas aeruginosa Clinical Strains in 16 Spanish Hospitals
Maria Garcia-Castillo et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2011)
A Novel Approach to Pharmacodynamic Assessment of Antimicrobial Agents: New Insights to Dosing Regimen Design
Vincent H. Tam et al.
PLOS COMPUTATIONAL BIOLOGY (2011)
Impact of AmpC overexpression on outcomes of patients with Pseudomonas aeruginosa bacteremia
Vincent H. Tam et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2009)
Clinical cure of ventilator-associated pneumonia treated with piperacillin/tazobactam administered by continuous or intermittent infusion
Leonardo Lorente et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2009)
Pharmacodynamic Modeling of Aminoglycosides against Pseudomonas aeruginosa and Acinetobacter baumannii: Identifying Dosing Regimens To Suppress Resistance Development
Vincent H. Tam et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Impact of drug-exposure intensity and duration of therapy on the emergence of Staphylococcus aureus resistance to a quinolone antimicrobial
V. H. Tam et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Clinical pharmacodynamics of meropenem in patients with lower respiratory tract infections
Chonghua Li et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
The impact of multidrug resistance on the outcomes of critically ill patients with Gram-negative bacterial pneumonia
Andrea L. H. Kwa et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2007)
The relationship between quinolone exposures and resistance amplification is characterized by an inverted U: A new paradigm for optimizing pharmacodynamics to counterselect resistance
Vincent H. Tam et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Pharmacokinetics-pharmacodynamics of antimicrobial therapy: It's not just for mice anymore
Paul G. Ambrose et al.
CLINICAL INFECTIOUS DISEASES (2007)
Development of high-level ceftazidime resistance via single-base substitutions of blaCTX-M-3 in hyper-mutable Escherichia coli
E Karisik et al.
CLINICAL MICROBIOLOGY AND INFECTION (2006)
Optimization of meropenem minimum concentration/MIC ratio to suppress in vitro resistance of Pseudomonas aeruginosa
VH Tam et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Bacterial-population responses to drug-selective pressure:: Examination of garenoxacin's effect on Pseudomonas aeruginosa
VH Tam et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Empiric treatment of multidrug-resistant Burkholderia cepacia lung exacerbation in a patient with cystic fibrosis:: Application of pharmacodynamic concepts to meropenem therapy
JL Kuti et al.
PHARMACOTHERAPY (2004)
Emergence of resistant Streptococcus pneumoniae in an in vitro dynamic model that simulates moxifloxacin concentrations inside and outside the mutant selection window:: related changes in susceptibility, resistance frequency and bacterial killing
SH Zinner et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Activities of moxifloxacin against, and emergence of resistance in, Streptococcus pneumoniae and Pseudomonas aeruginosa in an in vitro pharmacokinetic model
AP MacGowan et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Prevention of resistance: A goal for dose selection for antimicrobial agents
GL Drusano
CLINICAL INFECTIOUS DISEASES (2003)
Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen
CK Stover et al.
NATURE (2000)
分享论文
